1. Kim BJ, Lee SH. Prognostic impact of cerebral small vessel disease on stroke outcome.
J Stroke 2015;17:101-110.
2. Smith EE, Nandigam KR, Chen YW, Jeng J, Salat D, Halpin A, et al. MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage.
Stroke 2010;41:1933-1938.
3. Ku HL, Chi NF. Cerebral lobar microhemorrhages detection by high magnetic field susceptibility weighted image: a potential diagnostic neuroimage technique of Alzheimer’s disease.
Med Hypotheses 2011;76:840-842.
4. Abd Elaziz E, Yehia A, Elfatatry A. Importance of susceptibility weighted imaging (SWI) in management of cerebro-vascular strokes (CVS).
Alexandria J Med 2014;50:83-91.
5. Yamazoe M, Maeda M, Umino M, Tomimoto H, Sakuma H. Cerebral microbleeds identified by susceptibility-weighted imaging in two cases of Fabry disease without neurological symptoms.
Open J Med Imaging 2015;5:194-198.
6. Kim TW, Lee SJ, Lee KS, Kim YI, Koo J, Choi EJ, et al. The prevalence and associated cerebrovascular risk factors of cerebral microbleeds in Korean ischemic stroke patients. J Neurocrit Care 2013;6:75-81.
7. Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.
Front Neurol 2014;4:205.
8. Uetani H, Hirai T, Hashimoto M, Ikeda M, Kitajima M, Sakamoto F, et al. Prevalence and topography of small hypoteintense foci suggesting microbleeds on 3T susceptibility-weighted imaging in various types of dementia.
AJNR Am J Neuroradiol 2013;34:984-989.
9. Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia.
J Magn Reson Imaging 2010;31:142-148.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
Neurology 1984;34:939-994.
11. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging.
AJR Am J Roentgenol 1987;149:351-356.
12. Harper L, Barkhof F, Fox NC, Schott JM. Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.
J Neurol Neurosurg Psychiatry 2015;86:1225-1233.
13. Kang YW, Na DL, Han SH. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc 1997;15:300-308.
14. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Committee (JNC 8).
JAMA 2014;311:507-520.
15. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, et al. The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds.
Neurology 2009;73:1759-1766.
16. Chan S, Kartha K, Yoon SS, Desmond DW, Hilal SK. Multifocal hypointense cerebral lesions on gradient-echo MR are associated with chronic hypertension.
AJNR Am J Neuroradiol 1996;17:1821-1827.
17. Jackson CA, Sudlow CL. Is hypertension a more frequent risk factor for deep than for lobar supratentorial intracerebral haemorrhage?
J Neurol Neurosurg Psychiatry 2006;77:1244-1252.
18. Chen YC, Wu YR, Hsu WC, Chen CM, Lee TH, Chen ST. Basal ganglia-thalamic hemorrhage in young adults: a hospital-based study.
Cerebrovasc Dis 2006;22:33-39.
19. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting.
Brain 2007;130:1988-2003.
20. Vernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MM, van der Lugt A. Cerebral microbleeds: accelerated 3D T2
*-weighted GRE MR imaging versus conventional 2D T2
*-weighted GRE MR imaging for detection.
Radiology 2008;248:272-277.
21. Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review.
J Clin Neurol 2011;7:1-9.
22. Park JH, Seo SW, Kim C, Kim GH, Noh HJ, Kim ST, et al. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
Ann Neurol 2013;73:584-593.
23. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.
Neurology 2008;70:1208-1214.
24. Smith EE. Leukoaraiosis and stroke.
Stroke 2010;41(10 Suppl):S139-S143.
25. Song TJ, Kim JK, Lee HS, Nam CM, Nam HS, Kim YD, et al. Distribution of cerebral microbleeds determines their association with impaired kidney function.
J Clin Neurol 2014;10:222-228.
26. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-ShahiSalman R, Warach S, et al. Cerebral microbleeds: a guide to detection and interpretation.
Lancet Neurol 2009;8:165-174.
27. Vinters HV, Gilbert JJ. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.
Stroke 1983;14:924-928.
28. Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.
Neurology 2002;58:1629-1634.
29. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study.
Stroke 2004;35:1831-1835.
30. Roob G, Schmidt R, Kapeller P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population.
Neurology 1999;52:991-994.
31. Tsushima Y, Tanizaki Y, Aoki J, Endo K. MR detection of microhemorrhages in neurologically healthy adults.
Neuroradiology 2002;44:31-36.
32. Lee SH, Bae HJ, Ko SB, Kim H, Yoon BW, Roh JK. Comparative analysis of the spatial distribution and severity of cerebral microbleeds and old lacunes.
J Neurol Neurosurg Psychiatry 2004;75:423-427.
33. Nagasawa J, Kiyozaka T, Ikeda K. Prevalence and clinicoradiological analyses of patients with Alzheimer disease coexisting multiple microbleeds.
J Stroke Cerebrovasc Dis 2014;23:2444-2449.
34. Chiang GC, Cruz Hernandez JC, Kantarci K, Jack CR Jr, Weiner MW. Alzheimer’s Disease Neuroimaging Initiative.
AJNR Am J Neuroradiol 2015;36:1635-1641.
35. Shams S, Martola J, Cavallin L, Granberg T, Shams M, Aspelin P, et al. SWI or T2: which MRI sequence to use in the detection of cerebral microbleeds? The Karolinska Imaging Dementia study.
AJNR Am J Neuroradiol 2015;36:1089-1095.
36. Goos JD, van der Flier WM, Knol DL, Pouwels PJ, Scheltens P, Barkhof F, et al. Clinical relevance of improved microbleed detection by susceptibility-weighted magnetic resonance imaging.
Stroke 2011;42:1894-900.